Antimicrobial peptide structure and mechanism of action: a focus on the role of membrane structure TH Lee, K N Hall, MI Aguilar Current topics in medicinal chemistry 16 (1), 25-39, 2016 | 486 | 2016 |
β-amino acids: Versatile peptidomimetics DL Steer, RA Lew, P Perlmutter, A Smith, MI Aguilar Current medicinal chemistry 9 (8), 811-822, 2002 | 390 | 2002 |
Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors S Bosnyak, ES Jones, A Christopoulos, MI Aguilar, WG Thomas, ... Clinical science 121 (7), 297-303, 2011 | 315 | 2011 |
Lipid-induced conformation and lipid-binding properties of cytolytic and antimicrobial peptides: determination and biological specificity SE Blondelle, K Lohner, MI Aguilar Biochimica et Biophysica Acta (BBA)-Biomembranes 1462 (1-2), 89-108, 1999 | 293 | 1999 |
The β-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism S Petratos, QX Li, AJ George, X Hou, ML Kerr, SE Unabia, I Hatzinisiriou, ... Brain 131 (1), 90-108, 2008 | 232 | 2008 |
Transthyretin and familial amyloidotic polyneuropathy: recent progress in understanding the molecular mechanism of neurodegeneration X Hou, MI Aguilar, DH Small The FEBS journal 274 (7), 1637-1650, 2007 | 228 | 2007 |
Analysis of antimicrobial peptide interactions with hybrid bilayer membrane systems using surface plasmon resonance H Mozsolits, HJ Wirth, J Werkmeister, MI Aguilar Biochimica et Biophysica Acta (BBA)-Biomembranes 1512 (1), 64-76, 2001 | 199 | 2001 |
Protein folding at emulsion oil/water interfaces J li Zhai, L Day, MI Aguilar, TJ Wooster Current Opinion in Colloid & Interface Science 18 (4), 257-271, 2013 | 195 | 2013 |
HPLC of Peptides and Proteins MI Aguilar HPLC of Peptides and Proteins 251, 3-8, 2004 | 191 | 2004 |
Physicochemical basis of amino acid hydrophobicity scales: evaluation of four new scales of amino acid hydrophobicity coefficients derived from RP-HPLC of peptides MCJ Wilce, MI Aguilar, MTW Hearn Analytical chemistry 67 (7), 1210-1219, 1995 | 189 | 1995 |
Studies on the membrane interactions of the cyclotides kalata B1 and kalata B6 on model membrane systems by surface plasmon resonance H Kamimori, K Hall, DJ Craik, MI Aguilar Analytical biochemistry 337 (1), 149-153, 2005 | 155 | 2005 |
[1] High-resolution reversed-phase high-performance liquid chromatography of peptides and proteins MI Aguilar, MTW Hearn Methods in enzymology 270, 3-26, 1996 | 152 | 1996 |
Crystal structure of the soluble form of the redox‐regulated chloride ion channel protein CLIC4 DR Littler, NN Assaad, SJ Harrop, LJ Brown, GJ Pankhurst, P Luciani, ... The FEBS journal 272 (19), 4996-5007, 2005 | 147 | 2005 |
β-Amino acid-containing hybrid peptides—new opportunities in peptidomimetics MI Aguilar, AW Purcell, R Devi, R Lew, J Rossjohn, AI Smith, P Perlmutter Organic & Biomolecular Chemistry 5 (18), 2884-2890, 2007 | 145 | 2007 |
Surface plasmon resonance spectroscopy: an emerging tool for the study of peptide–membrane interactions H Mozsolits, MI Aguilar Peptide Science: Original Research on Biomolecules 66 (1), 3-18, 2002 | 144 | 2002 |
Cholesterol is necessary both for the toxic effect of Aβ peptides on vascular smooth muscle cells and for Aβ binding to vascular smooth muscle cell membranes S Subasinghe, S Unabia, CJ Barrow, SS Mok, MI Aguilar, DH Small Journal of neurochemistry 84 (3), 471-479, 2003 | 142 | 2003 |
Reversed-phase high-performance liquid chromatography MI Aguilar HPLC of peptides and proteins: Methods and protocols, 9-22, 2004 | 140 | 2004 |
β‐Amyloid protein oligomers induced by metal ions and acid pH are distinct from those generated by slow spontaneous ageing at neutral pH GMJA Klug, D Losic, Supundi, S Subasinghe, MI Aguilar, LL Martin, ... European Journal of Biochemistry 270 (21), 4282-4293, 2003 | 139 | 2003 |
Structural rearrangement of β-lactoglobulin at different oil–water interfaces and its effect on emulsion stability J Zhai, TJ Wooster, SV Hoffmann, TH Lee, MA Augustin, MI Aguilar Langmuir 27 (15), 9227-9236, 2011 | 135 | 2011 |
Epitope discovery and their use in peptide based vaccines N L Dudek, P Perlmutter, I Aguilar, N P Croft, A W Purcell Current pharmaceutical design 16 (28), 3149-3157, 2010 | 133 | 2010 |